Severe aplastic anaemia
Treatment Phase: Initial treatment - Second line treatment
Clinical criteria:
-
The condition must be severe aplastic anaemia,
AND
-
Patient must not have achieved an adequate response to prior immunosuppressive therapy including anti-thymocyte antibody and ciclosporin; OR
-
Patient must have relapsed following prior immunosuppressive therapy including anti-thymocyte antibody and ciclosporin,
AND
-
Patient must not receive more than 16 weeks of treatment under this restriction.
The authority application must be made via the online PBS Authorities (real time assessment), or in writing via HPOS form upload or mail and must include:
(a) prior immunosuppressive therapy, including dates of treatment.
If the application is submitted through HPOS form upload or mail, it must include:
(i) details of the proposed prescription; and
(ii) a completed authority application form relevant to the indication and treatment phase (the latest version is located on the website specified in the Administrative Advice).